Synakis
PrivateLast Round
Pre Seed
May 26, 2026
Total Funding Raised
$2.04M
Momentum Score
25 /100
Company Overview
Synakis is a biotechnology company developing novel biomaterial-based treatments for ocular injuries and diseases.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synakis Comps
Public and private peers based on sector, stage, and business model.
Synakis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | May 26, 2026 | ||||
| Accelerator | Mar 12, 2026 |
Key People
Founding team and executive leadership
Synakis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canadian Glycomics Network | Pre Seed |
| TIAP | Pre Seed |
| Ontario Genomics | Accelerator |
| Chiefswood Private Capital Inc. | Pre Seed |
| Ontario Centre of Innovation | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 26, 2026
$1.89M round led by TIAP and Chiefswood Private Capital.
- Apr 19, 2026
Monthly visitors grew 360% MoM, from 226 to 1K.
Synakis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Synakis's valuation, stock price, and market status.
Firmographic Details
HeadquartersToronto
Employee Range4
Year Founded2019
Last FundingMay 26, 2026
